CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells

Aurelie Thedrez, Claudia De Lalla, Sophie Allain, Luca Zaccagnino, Stephane Sidobre, Claudio Garavaglia, Giovanna Borsellino, Paolo Dellabona, Marc Bonneville, Emmanuel Scotet, Giulia Casorati

Research output: Contribution to journalArticlepeer-review


The CD4 coreceptor is crucial in the activation of major histocompatibility complex (MHC) class II restricted CD4+ T lymphocytes by binding the same MHC class as the T-cell receptor (TCR) and by potentiating TCR-dependent signaling. CD4 is also expressed by invariant natural killer T cells (iNKT), which recognize natural and synthetic lipid antigens, such as α-galactosyl ceramide (α-GalCer), in association with the MHC class I-like CD1d molecule. Human iNKT cells can be divided into 2 major subsets depending on CD4 expression: CD4+ iNKT preferentially produce T-helper (Th)0/Th2 cytokines, whereas CD4- iNKT cells produce Th1 cytokines after antigenic activation. Cytokines produced by iNKT may have immunomodulatory roles in various physiopathologic contexts, but their mode of regulation by iNKT cells remains ill-defined. Using blocking reagents neutralizing CD4 binding, experimental systems where MHC class II molecules are absent and recombinant α-GalCer/CD1d complexes, we show that CD4 potentiates human iNKT cell activation by engaging CD1d molecules. These results indicate that the CD4 coreceptors may contribute to the fine tuning of iNKT cells reactivity.

Original languageEnglish
Pages (from-to)251-258
Number of pages8
Issue number1
Publication statusPublished - Jul 1 2007

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells'. Together they form a unique fingerprint.

Cite this